FDA Approved: LUBIPROSTONE — Original Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Teva's Lubiprostone generic under an original application (ANDA 209920). This marks approval of a generic version of lubiprostone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Constipation
• Irritable Bowel Syndrome with Constipation

Drugs mentioned

• LUBIPROSTONE (lubiprostone)

Snippet

ORIG AP for LUBIPROSTONE (LUBIPROSTONE)